Charo, on the law faculty of the University of Wisconsin, Madison, has written extensively on
the ethics of embryonic stem cell research, served on President Barack Obama's FDA transition team, and was a member of President Bill Clinton's bioethics advisory council.
We should not only question the construct
of the «
ethics of curing,» as I will show, but we also need to look critically at reservations toward
research on
embryonic stem cells as they are expressed in our society.
* The role
of the US in global efforts to address pollutants that are broadly dispersed across national borders, such as greenhouse gasses, persistent organic pollutants, ozone, etc...; * How they view a president's ability to influence national science policy in a way that will persist beyond their term (s), as would be necessary for example to address global climate change or enhancement
of science education nationwide; * Their perspective on the relative roles that scientific knowledge,
ethics, economics, and faith should play in resolving debates over
embryonic stem cell research, evolution education, human population growth, etc... * What specific steps they would take to prevent the introduction
of political or economic bias in the dissemination and use
of scientific knowledge; * (and many more...)